Delivery Order SPE2DR25D1017-SPE2DR26F9AXY
- Not listed
- The Defense Logistics Agency awarded a $5,438.88 delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. The award, made on November 12, 2025, with an ultimate completion date of November 13, 2025, represents a non-competitive delivery order issued against AmerisourceBergen's larger pharmaceutical supply contract vehicle. The pharmaceutical will be delivered to the company's corporate office location in...
- The Defense Logistics Agency awarded a $6,125.90 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets, with performance in Conshohocken, Pennsylvania and completion targeted for December 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a $7,520.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets, with an ultimate completion date of December 8, 2025. This non-set-aside competitive award was issued on December 5, 2025, with performance to be completed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, was...
- The Defense Logistics Agency awarded a delivery order valued at $15,357.37 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on December 5, 2025, with completion scheduled for December 8, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $6,458.62 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-unit package) under a firm fixed price contract with a ceiling value of $1,163.89. This non-set-aside, competitively awarded delivery order is scheduled for completion by November 26, 2025, just one day after the award date of November 25, 2025. The award represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $9,980.40 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 11, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,789.34 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on November 10, 2025, with completion scheduled for November 12, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a $2,853.03 delivery order to AmerisourceBergen Drug Corp for Arimidex 1 mg tablets (30-count units) with an ultimate completion date of October 28, 2025. This is a firm fixed-price, non-set-aside contract awarded on October 27, 2025, to be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9AXYDelivery Order
The Defense Logistics Agency awarded a $11,611.24 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets under a firm fixed-price contract. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a small-value pharmaceutical procurement with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion vehicle that runs through December 2026 and serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive federal contract portfolio primarily with the Defense Logistics Agency and its Medical Supply Chain. The company's federal awards demonstrate consistent capability in delivering a broad spectrum of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialized healthcare commodities—across multiple therapeutic domains to support military and veteran healthcare systems. This particular award for Arimidex, an aromatase inhibitor used in cancer treatment, exemplifies the company's role as a critical vendor for specialized pharmaceutical procurement supporting Department of Defense medical requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.6k | 12/4/25 |